There are 17 papers on FAS in aging research: 4 trials and 10 observational studies in people, 2 in animals, 1 review.
17 papers study it4 findings
“Higher pre-KT levels tumor necrosis factor receptor superfamily member 6 (FAS) and MMP-9 levels were independently associated with lower KT function one year after KT.”
- Human trial4
- Humans10
- Animals2
Interventions
2Estradiol
downin humans1
1 study
Estradiol
downin humans1
Estradiol decreases FAS in humans (compared with placebo) (-695 pg/mL (p = .036)).
Human trialcompared with placebotransdermal36 monthsfemalesn = 34
Estradiol decreases FAS in humans.
Human trial48 months
Conjugated equine estrogens
downin humans1
1 study
Conjugated equine estrogens
downin humans1
Conjugated equine estrogens decrease FAS in humans (−1374 pg/ml (95% CI −1940, −711)).
Human trial48 months
Associations
1Kidney transplant function
downin humans1
1 study
Kidney transplant function
downin humans1
FAS is associated with kidney transplant function in humans (pre-transplant biomarker levels in patients undergoing kidney transplantation).
Humanspre-transplant biomarker levels in patients undergoing kidney transplantationplasma1 year after kidney transplantation61.4% malesn = 197